Ron Lloyd is executive vice president and president of hospital therapies at Mallinckrodt Pharmaceuticals. He has executive responsibility and directly manages all commercialization efforts for the company's hospital portfolio within its Specialty Brands segment. Mr. Lloyd is a member of Mallinckrodt’s executive committee. Mr. Lloyd has nearly 30 years of experience in the U.S. and internationally in sales and marketing, new product planning, business development, strategic planning, and general management in the pharmaceutical industry. Before joining Mallinckrodt, Mr. Lloyd was president of immunology, leading commercial operations in North America and Europe for Baxalta, and previously held various commercial leadership positions within the bioscience business at Baxter Healthcare. He also served in a number of commercial and business development capacities at Abbott Laboratories. Mr. Lloyd holds a bachelor's degree in management science from Westminster College and a master's degree in Industrial Administration from Carnegie Mellon University.